Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	136.92	131.82	-80.16	-629.92	172.15	27.49
Depreciation & Amortization	123.68	38.35	38.77	34.02	31.7	30.76
Other Amortization	5.75	3.03	2.93	2.41	1.68	1.58
Other Operating Activities	-138.59	-130.53	85.41	451.15	-269.58	-85.54
Operating Cash Flow	127.75	42.67	46.95	-142.34	-64.06	-25.71
Operating Cash Flow Growth	-	-9.12%	-	-	-	-
Capital Expenditures	-26.14	-31.16	-50.67	-59.26	-30.39	-9.25
Sale of Property, Plant & Equipment	0.13	0.08	1.32	0.06	0.21	0
Sale (Purchase) of Intangibles	-5.55	-8.41	-10.34	-18.38	-14.97	-23.38
Other Investing Activities	-6.13	-6.13	-8.24	5.25	-0.41	-
Investing Cash Flow	-31.19	-45.62	-67.93	-72.34	-45.56	-32.64
Short-Term Debt Issued	-	-	50	-	-	-
Long-Term Debt Issued	-	2,150	3,248	2,291	2,329	1,541
Total Debt Issued	2,125	2,150	3,298	2,291	2,329	1,541
Long-Term Debt Repaid	-	-2,139	-3,240	-1,988	-2,149	-1,443
Total Debt Repaid	-2,150	-2,139	-3,240	-1,988	-2,149	-1,443
Net Debt Issued (Repaid)	-24.3	10.67	57.48	303.42	179.73	97.72
Issuance of Common Stock	-	-	45.86	-	-	-
Common Dividends Paid	-	-	-7.86	-82.53	-58.95	-26.14
Other Financing Activities	11.63	11.43	-0.21	-0.1	-0.04	-0.09
Financing Cash Flow	-12.67	22.1	95.27	220.79	120.74	71.49
Foreign Exchange Rate Adjustments	-1.21	-0.52	0.31	-0.39	0.13	-0.23
Net Cash Flow	82.68	18.64	74.59	5.74	11.25	12.91
Free Cash Flow	101.61	11.51	-3.72	-201.6	-94.44	-34.96
Free Cash Flow Margin	2.58%	0.31%	-0.11%	-5.79%	-1.96%	-1.28%
Free Cash Flow Per Share	0.07	0.01	-0.00	-0.15	-0.07	-0.03
Cash Interest Paid	63.94	68.11	60.81	41.29	32.63	38.57
Cash Income Tax Paid	42.09	33.89	20.56	39.52	39.7	2.94
Levered Free Cash Flow	187.33	-16.53	31.75	479.12	-143.76	-75.73
Unlevered Free Cash Flow	231.66	28.45	70.4	504.15	-122.93	-54.67

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.